INVESTORS & MEDIA

Event

H.C. Wainwright & Co. – Unlocking the Full Potential of RNAi With World-Class Novel Target Identification: Regeneron Genomics and Alnylam’s RNAi Platform Collaboration Update

Dec 6 2:00 PM EST Dec 6, 2021 | 2:00 PM EST

IR Tools